In March 2024, Eli Lilly and Company launched the next phase of its "Get Better" corporate branding campaign, focusing on obesity
The World Anti-Doping Agency says BPC-157 poses a risk to athlete health because it has not been studied extensively in humans
Those who have switched from a brand-name GLP-1 to a compounded version are twice as likely as those who have switched from compounded to brand-name to cite cost or insurance coverage as their primary reason for switching (66% vs
Continuous glucose monitoring (FreeStyle Libre 2) was used to assess daily time spent in euglycaemia (3.9-7.8 mmol/l) and markers of GV, including mean absolute glucose (MAG), coefficient of variation (CV), and mean amplitude of glucose excursions (MAGE)
Potential Side Effects As with other incretin-based therapies, Retatrutide may cause: Nausea and vomiting Constipation or diarrhea Fatigue or mild dizziness Injection site reactions Mild elevation in heart rate Most side effects tend to resolve over time or with dose adjustment
Clinical studies have documented substantial IGF-1 elevations in tesamorelin-treated patients (Falutz et al., 2007)
